Physician profile
Jonathan Gonzalez
NPI 1386023463
$5,525.21
in general payments reported to CMS, 2019-2025
37 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,473 · 2020: $866 · 2021: $182 · 2022: $791 · 2023: $1,208 · 2024: $851 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,213.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $646.94 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Amgen INC. | $623.82 | 2019-2024 | Repatha, Otezla, Krystexxa |
| Astrazeneca Pharmaceuticals Lp | $481.71 | 2019-2024 | Airsupra, Breztri, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $385.48 | 2019-2024 | Jardiance, Synjardy |
| Glaxosmithkline, LLC. | $328.39 | 2019-2020 | |
| Lilly USA, LLC | $320.15 | 2019-2024 | Mounjaro, Jardiance, Zepbound |
| Amarin Pharma, INC. | $302.58 | 2019-2020 | |
| Eisai INC. | $277.48 | 2020-2024 | |
| Pfizer INC. | $238.03 | 2019-2023 | |
| Abbvie INC. | $223.78 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $177.24 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $155.20 | 2023 | Optimizer |
| Medtronic, INC. | $152.74 | 2022-2024 | Intellis Adaptivestim, Closurefast |
| Bayer Healthcare Pharmaceuticals INC. | $148.20 | 2022-2024 | |
| Inspire Medical Systems, INC. | $132.46 | 2023-2025 | Inspire |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.